Cell and Peptide-based Therapy for Ph+ Leukaemia
Team Lead: Dr Afsar Mian, Assistant Professor
Dr Afsar Mian is working on developing novel drugs and treatment approaches for treatment-resistant Leukaemia, a type of blood cancer. His current focus is on designing a cell and peptide-based method for treating Philadelphia-positive Leukaemia. It is expected that, unlike the existing treatment methods, the new therapy wouldn't require repetitive administration, hence, reducing treatment cost and drug manipulation risks.